• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research

From the Pages of Allergy Watch
For this month ’s issue of Annals, which focuses on vaccines, I’ve selected 3 article summaries from recent Allergy Watch that reviewed studies on various aspects of vaccines. The first reports data from the pivotal study showing the improved efficacy of the new recombinant subunit herpes zoster vaccine. The n ext review describes a report of a unique vaccine for cats that induces IgG blocking antibodies for Fel d 1. The last review shows discrepant results of pneumococcal titers from different labs.
Source: Annals of Allergy, Asthma and Immunology - April 23, 2020 Category: Allergy & Immunology Authors: David A. Khan, Gerald B. Lee, Stanley M. Fineman Tags: Special Series Source Type: research

From the pages of AllergyWatch
For this month's issue of Annals, which focuses on vaccines, there are 3 article summaries from recent AllergyWatch columns that reviewed studies on various aspects of vaccines. The first reports data from a pivotal study on the improved efficacy of the new recombinant subunit herpes zoster vaccine. The second review describes a report of a unique vaccine for cats that induces immunoglobulin G –blocking antibodies for Fel d 1. The third review reports discrepant results of pneumococcal titers from different laboratories.
Source: Annals of Allergy, Asthma and Immunology - April 23, 2020 Category: Allergy & Immunology Authors: David A. Khan, Gerald B. Lee, Stanley M. Fineman Tags: Special Series Source Type: research

Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome
This study was carried out after written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved by the Stanford University and UCLA Institutional Review Boards. Author Contributions MB provided patient care and obtained IRB approval. RO prepared histology images. MB, TT, and RB designed the research. TT and LP conducted experiments and analyzed data. MB made the molecular model. MB and TT wrote the manuscript. Funding Funding for this work came from the Jeffrey Modell Foundation and from the NIH/NIGMS (R01 GM110482 to MB)....
Source: Frontiers in Immunology - April 11, 2019 Category: Allergy & Immunology Source Type: research

Encephalitis in Australian children: contemporary trends in hospitalisation
Conclusion Hospitalisation of childhood encephalitis has slightly decreased in Australia. High rates of childhood immunisation have been associated with a reduction of varicella-associated encephalitis in Australian children. ADEM, an immune-mediated encephalitis, is the most common recognised cause of encephalitis in children. Young children (<1 year) have the highest admission rates. The high proportion of ‘unspecified’ encephalitis deaths and hospitalisations is an ongoing challenge.
Source: Archives of Disease in Childhood - December 14, 2015 Category: Pediatrics Authors: Britton, P. N., Khoury, L., Booy, R., Wood, N., Jones, C. A. Tags: Health policy, Immunology (including allergy), Meningitis, Vaccination / immunisation, Infection (neurology), Health economics, Health service research Original article Source Type: research